Business Segments Zhongzhi Pharmaceutical Holdings Limited
Equities
3737
KYG989611085
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5600 HKD | -5.08% |
|
-5.08% | -43.43% |
| 26/08 | Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| 18/07 | Zhongzhi pharmaceutical expects 90% decrease in HY net profit | RE |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Gross Profit: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceutical Manufacturing | 99Cr | 187.72Cr | 184.79Cr | 211.19Cr | 233.25Cr | |||||
Gross Profit | 70Cr | 76Cr | 78Cr | 98Cr | 107.61Cr | |||||
Drug Stores and Pharmacies | ||||||||||
Operation of Chain Pharmacies | - | - | 70Cr | 63Cr | 59Cr | |||||
Gross Profit | - | - | 29Cr | 24Cr | 21Cr | |||||
Operation of Chain Pharmacies (Excl. Operation of On-Line Pharmacies) | 62Cr | 62Cr | - | - | - | |||||
Gross Profit | 25Cr | 26Cr | - | - | - | |||||
Elimination of Intersegment Sales | -6.95Cr | -82Cr | -72Cr | -70Cr | -71Cr | |||||
Online Drug Retail and Pharmacies | ||||||||||
Operation of On-Line Pharmacies | 6.29Cr | 7.03Cr | - | - | - | |||||
Gross Profit | 3.91Cr | 4.08Cr | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Mainland China | 160.39Cr | 174.65Cr | 182.59Cr | 204.98Cr | 221.48Cr | |||||
Total Assets | 142.05Cr | 152.41Cr | 187.53Cr | 179.26Cr | 198.71Cr | |||||
Interest Expense | -52.18L | -70.8L | -65.55L | -78.68L | -69.94L | |||||
Income Tax Expense | 2.86Cr | 94.47L | 2.37Cr | 4.34Cr | 5.08Cr | |||||
D&A | 9.75Cr | 8.51Cr | 9.36Cr | 9.95Cr | 11Cr | |||||
CAPEX | -12Cr | -19Cr | -8.84Cr | -17Cr | -14Cr | |||||
Gross Profit | 99Cr | 106.14Cr | 107.23Cr | 121.81Cr | 128.84Cr | |||||
Net Income | 14Cr | 5.21Cr | 11Cr | 16Cr | 9.52Cr | |||||
EBT | 17Cr | 6.18Cr | 13Cr | 21Cr | 15Cr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition